User profiles for E. Baraldi

Eugenio Baraldi

- Verified email at unipd.it - Cited by 20630

Enrico Baraldi

- Verified email at angstrom.uu.se - Cited by 3394

elena baraldi

- Verified email at unibo.it - Cited by 3037

Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

…, D Radi, C Argento, E Baraldi… - Human reproduction …, 2010 - academic.oup.com
BACKGROUND In women, anti-Müllerian hormone (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach

PLP Brand, E Baraldi, H Bisgaard… - European …, 2008 - Eur Respiratory Soc
… Total serum immunoglobulin E measurements in early life are not predictive of outcome 56.
Although elevated eosinophilic cationic protein levels in preschool wheezers are associated …

Chronic lung disease after premature birth

E Baraldi, M Filippone - New England Journal of Medicine, 2007 - Mass Medical Soc
Bronchopulmonary dysplasia has become the most common chronic lung disease of infancy.
This review summarizes the patterns and pathogenesis of chronic lung impairment that …

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label …

F Van Leth, P Phanuphak, K Ruxrungtham, E Baraldi… - The Lancet, 2004 - thelancet.com
Background The 2NN Study was a randomised comparison of the non-nucleoside reverse-transcriptase
inhibitors (NNRTI) nevirapine and efavirenz. Methods In this multicentre, open-…

International consensus on (ICON) pediatric asthma

…, G Wong, H Zar, CA Akdis, LB Bacharier, E Baraldi… - Allergy, 2012 - Wiley Online Library
Asthma is the most common chronic lower respiratory disease in childhood throughout the
world. Several guidelines and/or consensus documents are available to support medical …

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

…, AC Olin, A Amann, B Antus, E Baraldi… - European …, 2017 - Eur Respiratory Soc
Breath tests cover the fraction of nitric oxide in expired gas (F ENO ), volatile organic compounds
(VOCs), variables in exhaled breath condensate (EBC) and other measurements. For …

Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years

F Buchvald, E Baraldi, S Carraro, B Gaston… - Journal of Allergy and …, 2005 - Elsevier
BACKGROUND: Fractional exhaled nitric oxide (FE NO ) is used in monitoring of asthma.
OBJECTIVES: The aim of this multicenter study was to establish normal values of FE NO and …

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

…, A Greenough, E Baraldi… - The Lancet Infectious …, 2018 - thelancet.com
The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly
recognised, not only in infants, but also in older adults (aged ≥65 years). Advances in …

Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide

MJ Macias, M Hyvönen, E Baraldi, J Schultz, M Sudol… - Nature, 1996 - nature.com
THE WW domain is a new protein module with two highly conserved tryptophans that binds
proline-rich peptide motifs in vitro. It is present in a number of signalling and regulatory …

[HTML][HTML] Systems medicine and integrated care to combat chronic noncommunicable diseases

…, SE Antonarakis, A Avignon, A Ballabio, E Baraldi… - Genome medicine, 2011 - Springer
We propose an innovative, integrated, cost-effective health system to combat major non-communicable
diseases (NCDs), including cardiovascular, chronic respiratory, metabolic, …